Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

1.83
Delayed Data
As of Feb 12
 -0.02 / -1.08%
Today’s Change
1.79
Today|||52-Week Range
9.50
-12.44%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close1.85
Today’s open1.83
Day’s range1.79 - 1.85
Volume33,155
Average volume (3 months)54,683
Market cap$31.0M
Dividend yield--
Data as of 3:59pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+42.50%
Earnings growth (this year)+12.09%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.94

Competitors

 Today’s
change
Today’s
% change
OGENOragenics Inc+0.03+3.91%
STDYSteadymed Ltd+0.14+6.48%
ABIOARCA Biopharma Inc+0.09+2.62%
HEBHemispherx Biopharma...+0.00+2.55%
Data as of 3:59pm ET, 02/12/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$5.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
James Garner
COO, Head-Administration &
Finance
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts

Partner Offers